PubMed HealthSearch

Biomedical subjects

E Gale

Publications and source records attributed to E Gale.

11 recordsLinked to original sources

Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies.

Quinine-ingestion has been associated with immune-mediated recurrent pancytopenia, hemolysis, and renal failure. The structure of fluoroquinolone antibiotics is similar to the structure of quinine. Over a 3 month period, three patients at our institution developed hemolysis and renal failure following ingestion of the fluoroquinolone antibiotic temafloxacin. Two of the three patients required hemodialysis. Following withdrawal from the drug, the hemolysis resolved and the renal function eventually returned to normal in all three patients. One patient also had a transient mild thrombocytopenia. Sera from all three patients were tested for drug-dependent antibodies to red blood cells, platelets, and neutrophils. Temafloxacin-dependent red cell antibodies were detected in one patient, and temafloxacin-dependent red cell and neutrophil antibodies were detected in a second patient. No temafloxacin-dependent antibodies were detected in the third patient. Sera from all three patients were also tested for quinine and quinidine-dependent antibodies to red cells, platelets, and neutrophils. Sera from the patient without temafloxacin-dependent red cell antibodies reacted with red cells in the presence of quinine. These results suggest that, at least in some patients, the toxicities associated with temafloxacin are immune mediated.

Acute Kidney Injury

Causes of hypoglycaemia.

Hypoglycaemia represents a disturbance in carbohydrate metabolism that threatens to deprive the brain of its principal fuel, and its physiological consequences are mediated almost exclusively by the CNS. Although some find the distinction pedantic, it is useful to reserve the term hypoglycaemia for this biochemical state, and neuroglycopenia for the clinical syndrome that results.

Alcoholism

Patient self-monitoring of blood glucose and refinements of conventional insulin treatment.

The compelling evidence that blood glucose control will slow or prevent microvascular complications has stimulated research to find better ways of managing insulin-dependent diabetes. The excellent results obtained with "open loop" insulin infusion systems suggest that the relative failure of conventional treatment is the result of (1) a lack of appropriate feedback to the patient and (2) the use of insulin regimens which do not mimic physiologic insulinemia, particularly in the basal state. Doctors regard blood glucose measurements as an essential part of diabetic management and extension of this technology to patients has added a new dimension, particularly in the assessment of control. Nevertheless, home blood-glucose monitoring will not necessarily improve diabetic control; the best results have been obtained when it has been offered as part of a package deal which includes more investment of time and interest by patients and doctor together with joint discussions of problems and changes in treatment. The biggest problem with conventional twice daily insulin regimens is to sustain constant basal insulin levels during the night. Attempts to obtain fasting normoglycemia with an injection before supper often result in nocturnal hyperinsulinemia and hypoglycemia. This can usually be resolved by changing to a three times daily regimen with an extra injection of NPH insulin at bedtime. Three times daily insulin injections with feedback from home blood-glucose monitoring give as good blood glucose control as infusion systems and are cheaper and more acceptable to patients.

Blood Glucose

Hypoglycaemia.

Explore the source record for details and available documents.

Adenoma, Islet Cell

Brittle diabetes.

Explore the source record for details and available documents.

Adolescent

A critical evaluation of methods of monitoring diabetic control.

Patients with insulin-treated diabetes need to be actively involved in their own treatment. We have found that measurement of blood rather than urinary glucose by our diabetic patients leads to greater understanding and enthusiasm as well as to better control of blood glucose. Home blood glucose monitoring is complementary to rather than a substitute for measurement of hemoglobin A1. The latter provides an objective index of long-term control that is of more use to the doctor than to the patient. The former gives the patient information that enables him to master his own disease from day to day.

Blood Glucose